Effect of Nonmyeloablative Hematopoietic Stem Cell Transplantation vs Continued Disease-Modifying Therapy on Disease Progression in Patients With Relapsing-Remitting Multiple Sclerosis: A Randomized Clinical Trial.
JAMA. 2019 Jan 15;321(2):165-174. doi: 10.1001/jama.2018.18743.
JAMA. 2019.
PMID: 30644983
Free PMC article.
Clinical Trial.